Related references
Note: Only part of the references are listed.Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Ribosomal Protein S6: A Potential Therapeutic Target against Cancer?
Yong Weon Yi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer
Kyu Sic You et al.
PHARMACEUTICALS (2021)
Roles of Rho-associated kinase in lung cancer (Review)
Muhammad Asyaari Zakaria et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Identification of Hub Genes and Pathways of Triple Negative Breast Cancer by Expression Profiles Analysis
Liqi Li et al.
CANCER MANAGEMENT AND RESEARCH (2021)
Targeted Therapeutic Strategies for Triple-Negative Breast Cancer
Ying Li et al.
FRONTIERS IN ONCOLOGY (2021)
Knockdown of Annexin-A1 Inhibits Growth, Migration and Invasion of Glioma Cells by Suppressing the PI3K/Akt Signaling Pathway
Liqing Wei et al.
ASN NEURO (2021)
Reduced expression of annexin A1 promotes gemcitabine and 5-fluorouracil drug resistance of human pancreatic cancer
Qing-Hua Liu et al.
INVESTIGATIONAL NEW DRUGS (2020)
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
Zhilin Zou et al.
CELL AND BIOSCIENCE (2020)
Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer
Fang Bai et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
DCST1-AS1 Promotes TGF-β-Induced Epithelial-Mesenchymal Transition and Enhances Chemoresistance in Triple-Negative Breast Cancer Cells via ANXA1
Li Tang et al.
FRONTIERS IN ONCOLOGY (2020)
Annexin A1: A Bane or a Boon in Cancer? A Systematic Review
Thanusha Ganesan et al.
MOLECULES (2020)
Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1
Mara Roxana Rubinstein et al.
EMBO REPORTS (2019)
Inhibition of Triple-Negative Breast Cancer Cell Aggressiveness by Cathepsin D Blockage: Role of Annexin A1
Mariana Alves Pereira Zoia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Annexin-A1-A Blessing or a Curse in Cancer?
Sok Lin Foo et al.
TRENDS IN MOLECULAR MEDICINE (2019)
Can Lycopene Impact the Androgen Axis in Prostate Cancer?: A Systematic Review of Cell Culture and Animal Studies
Catherine C. Applegate et al.
NUTRIENTS (2019)
Annexin A1-mediated inhibition of inflammatory cytokines may facilitate the resolution of inflammation in acute radiation-induced lung injury
Gaohua Han et al.
ONCOLOGY LETTERS (2019)
Triple-Negative Breast Cancer with High Levels of Annexin A1 Expression Is Associated with Mast Cell Infiltration, Inflammation, and Angiogenesis
Maiko Okano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Anticancer effect of nor-wogonin (5, 7, 8-trihydroxyflavone) on human triple-negative breast cancer cells via downregulation of TAK1, NF-κB, and STAT3
Amer Ali Abd El-Hafeez et al.
PHARMACOLOGICAL REPORTS (2019)
Inhibition of the AnxA1/FPR1 autocrine axis reduces MDA-MB-231 breast cancer cell growth and aggressiveness in vitro and in vivo
Lara Vecchi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2018)
Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype
Kenichi Harano et al.
PLOS ONE (2018)
Triple-Negative Breast Cancers: Systematic Review of the Literature on Molecular and Clinical Features with a Focus on Treatment with Innovative Drugs
Anna Diana et al.
CURRENT ONCOLOGY REPORTS (2018)
Annexin A1 in inflammation and breast cancer: a new axis in the tumor microenvironment
Leonardo A. Moraes et al.
CELL ADHESION & MIGRATION (2018)
The Yin and Yang of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers
Elizabeth Varghese et al.
CANCERS (2018)
How shall we treat early triple-negative breast cancer (TNBC): from the current standard to upcoming immuno-molecular strategies
Ji Hyun Park et al.
ESMO OPEN (2018)
Annexin A1 is involved in resistance to 5-FU in colon cancer cells
Hisashi Onozawa et al.
ONCOLOGY REPORTS (2017)
RAC1 GTP-ase signals wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers
Pradip De et al.
ONCOTARGET (2017)
SWI/SNF complex in cancer
Chao Lu et al.
NATURE GENETICS (2017)
Triple-negative breast cancer and the potential for targeted therapy
Jing-Ru Jhan et al.
PHARMACOGENOMICS (2017)
Annexin Al influences in breast cancer: Controversies on contributions to tumour, host and immunoediting processes
Yan Tu et al.
PHARMACOLOGICAL RESEARCH (2017)
Annexin-A1 enhances breast cancer growth and migration by promoting alternative macrophage polarization in the tumour microenvironment
Leonardo A. Moraes et al.
SCIENTIFIC REPORTS (2017)
Developing the WCRF International/University of Bristol Methodology for Identifying and Carrying Out Systematic Reviews of Mechanisms of Exposure-Cancer Associations
Sarah J. Lewis et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance
Tianjian Yu et al.
CHINESE JOURNAL OF CANCER RESEARCH (2017)
Annexin A1 localization and its relevance to cancer
Zied Boudhraa et al.
CLINICAL SCIENCE (2016)
ANXA1 inhibits miRNA-196a in a negative feedback loop through NF-kB and C-Myc to reduce breast cancer proliferation
Yi Yuan et al.
ONCOTARGET (2016)
Annexin A1 and the Resolution of Inflammation: Modulation of Neutrophil Recruitment, Apoptosis, and Clearance
Michelle Amantea Sugimoto et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
Brian D. Lehmann et al.
PLOS ONE (2016)
Annexin A1 contributes to pancreatic cancer cell phenotype, behaviour and metastatic potential independently of Formyl Peptide Receptor pathway
Raffaella Belvedere et al.
SCIENTIFIC REPORTS (2016)
Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting
Paula Garcia-Teijido et al.
CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2016)
Annexin-A1 controls an ERK-RhoA-NFκB activation loop in breast cancer cells
Pradeep Bist et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide
Marie Genin et al.
BMC CANCER (2015)
Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis
Marcelo Sobral-Leite et al.
BMC MEDICINE (2015)
Upregulated Annexin A1 promotes cellular invasion in triple-negative breast cancer
Maiko Okano et al.
ONCOLOGY REPORTS (2015)
Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling
Anjana Bhardwaj et al.
PLOS ONE (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
David Moher et al.
SYSTEMATIC REVIEWS (2015)
Formononetin Inhibits Migration and Invasion of MDA-MB-231 and 4T1 Breast Cancer Cells by Suppressing MMP-2 and MMP-9 Through PI3K/AKT Signaling Pathways
R. Zhou et al.
HORMONE AND METABOLIC RESEARCH (2014)
Annexin-A1 Regulates MicroRNA-26b*and MicroRNA-562 to Directly Target NF-κB and Angiogenesis in Breast Cancer Cells
Durkeshwari Anbalagan et al.
PLOS ONE (2014)
Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer
Christine Mehner et al.
ONCOTARGET (2014)
Differential Activation of Wnt-β-Catenin Pathway in Triple Negative Breast Cancer Increases MMP7 in a PTEN Dependent Manner
Nandini Dey et al.
PLOS ONE (2013)
Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects
John Stagg et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2013)
The role of annexin A1 in expression of matrix metalloproteinase-9 and invasion of breast cancer cells
Hyereen Kang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Annexin A1 is associated with gastric cancer survival and promotes gastric cancer cell invasiveness through the formyl peptide receptor/extracellular signal-regulated kinase/integrin beta-1-binding protein 1 pathway
Tsu-Yao Cheng et al.
CANCER (2012)
The mTOR Signalling Pathway in Human Cancer
Helena Populo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Annexin-1 signals mitogen-stimulated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2
Thippadey Khau et al.
FASEB JOURNAL (2011)
Clinical Significance of Annexin A1 Expression in Breast Cancer
Cha Kyong Yom et al.
JOURNAL OF BREAST CANCER (2011)
Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-κB: implication in breast cancer metastasis
P. Bist et al.
ONCOGENE (2011)
CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
Beverly A. Teicher et al.
CLINICAL CANCER RESEARCH (2010)
Annexin A1 regulates TGF-β signaling and promotes metastasis formation of basal-like breast cancer cells
Marjo de Graauw et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression
Li Yang et al.
TRENDS IN IMMUNOLOGY (2010)
LKB1 and AMP-activated protein kinase control of mTOR signalling and growth
R. J. Shaw
ACTA PHYSIOLOGICA (2009)
Role of macrophages in tumour progression
K. S. Siveen et al.
IMMUNOLOGY LETTERS (2009)
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
G. Solinas et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Annexin-I expression modulates drug resistance in tumor cells
Y Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Induction of MMP-9 in normal human bronchial epithelial cells by TNF-α via NF-κB-mediated pathway
A Hozumi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2001)
Share Paper
